APOE and dementia: In sub‐group analysis, among APOE ε3/ε4 heterozygotes, PRS modified dementia risk, with CID increasing from 10.8% (CI 7.2–16.3) in the low PRS tertile to 17.8% (CI 13.2–23.8) in the high (Table S6).